Orion OYJ (OTCMKTS:ORINY) Shares Up 7.1% - Here's What Happened

Key Points

• Orion OYJ's shares increased by 7.1% on Tuesday, reaching a trading high of $39.95, despite a significant drop in trading volume.
• Analyst ratings show a split, with Nordea Equity Research upgrading the stock to a "buy" while Zacks Research downgraded it to a "hold," resulting in an overall average rating of "Moderate Buy."
• The company announced a dividend of $0.2418 per share, with an impressive dividend yield of 127.0%, scheduled for payment on November 7th.

Shares of Orion OYJ Unsponsored ADR (OTCMKTS:ORINY - Get Free Report) shot up 7.1% during mid-day trading on Tuesday . The stock traded as high as $39.95 and last traded at $39.95. 196 shares were traded during trading, a decline of 54% from the average session volume of 423 shares. The stock had previously closed at $37.29.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on ORINY shares. Nordea Equity Research raised shares of Orion OYJ from a "hold" rating to a "buy" rating in a research report on Monday. Zacks Research downgraded shares of Orion OYJ from a "strong-buy" rating to a "hold" rating in a research report on Monday, September 8th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, Orion OYJ has an average rating of "Moderate Buy".

Orion OYJ Stock Performance

The business's 50-day moving average price is $39.02 and its 200-day moving average price is $35.40. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.86. The stock has a market cap of $11.28 billion, a P/E ratio of 27.18 and a beta of 0.09.

Orion OYJ (OTCMKTS:ORINY - Get Free Report) last issued its quarterly earnings data on Friday, July 18th. The company reported $0.33 earnings per share (EPS) for the quarter. Orion OYJ had a net margin of 22.61% and a return on equity of 38.68%. The firm had revenue of $472.57 million during the quarter. As a group, sell-side analysts expect that Orion OYJ Unsponsored ADR will post 1.18 earnings per share for the current fiscal year.

Orion OYJ Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be given a dividend of $0.2418 per share. The ex-dividend date of this dividend is Thursday, October 16th. This represents a dividend yield of 127.0%. Orion OYJ's payout ratio is presently 21.77%.

About Orion OYJ

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.